Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PLSE
#1951
Pulse Biosciences, Inc Common Stock (DE)
18.730
0
-0.58%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.58%
Monthly Change
+30.89%
6 month change
+3.20%
Year Change
+3.20%
Previous Close
18.840
0
Open
18.730
0
Bid
Ask
Low
18.730
0
High
18.730
0
Volume
54
Markets
US Stock Market
Healthcare
PLSE
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.09 M
29.8 M
37.59 M
55.23 M
67.27 M
67.99 M
—
Valuation ratios
Enterprise value
609.97 M
412.76 M
42.24 M
564.22 M
1.05 B
852.76 M
3.83 B
Price to earnings ratio
—
—
-1.6
-12.54
-18.97
12.71
-32.93
Price to sales ratio
—
—
133.32
—
—
2 643.82
—
Price to cash flow ratio
—
—
-1.99
-16.02
-27.98
17.1
-53.09
Price to book ratio
—
—
-41.51
11.93
8.85
11.47
19.35
Enterprise value to EBITDA ratio
-12.35
-12.19
-1.16
-36.96
—
-11.14
—
Profitability ratios
Return on assets %
1.21
1.17
0.75
0.71
0.4
-0.77
0.28
Return on equity %
2.18
1.78
26.03
0.95
0.47
-0.9
0.32
Return on invested capital %
761.9
1 240.68
1 276.4
1 075.01
1 538.65
-2 275.12
—
Gross margin %
—
-38.79
-1 606.29
—
—
-54
—
Operating margin %
—
4 443.86
8 293.86
—
—
-21.98 K
—
EBITDA margin %
—
-2 388.86
-5 190.43
—
—
-21.87 K
—
Net margin %
—
4 492.24
8 357.86
—
—
-20.79 K
—
Liquidity ratios
Quick ratio
—
3.62
10.39
—
—
10.51
48.14
Current ratio
2.95
4.3
10.39
6.76
11.88
10.53
48.17
Inventory turnover
—
0.1
2.91
—
—
—
—
Asset turnover
0
0.03
0.01
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.01
0
0
—
—
—
Long term debt to total equity ratio
—
0.01
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.39
0.69
0.62
-0.8
0.37
EBIT per share
—
—
-1.11
-0.34
—
-1.15
—
EBITDA per share
—
—
-1.07
-0.32
—
-1.14
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.8
0.92
2.02
1.2
5.97
Net current asset value per share
—
—
1.83
0.94
2.05
1.24
6.09
Tangible book value per share
—
—
0.14
0.99
2.03
1.27
6.15
Working capital per share
—
—
1.66
0.8
1.87
1.12
5.58
Book value per share
—
—
0.07
0.92
1.97
1.2
5.89
News
Pulse Biosciences chief commercial officer resigns effective immediately
Pulse Biosciences CCO Danahy sells $118k in PLSE stock
Oppenheimer raises Pulse Biosciences stock price target to $30
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Pulse Biosciences CCO Danahy sells $1.41 million in stock
Pulse Biosciences stock hits 52-week high at 22.76 USD
PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data
What's Going With Pulse Biosciences Stock On Monday? - Pulse Biosciences (NASDAQ:PLSE)
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.47%
Pulse Biosciences stock rises after positive cardiac catheter study data